BIRC2 Blockade Facilitates Immunotherapy of Hepatocellular Carcinoma

Genome-wide CRISPR/Cas9 screening was conducted to identify tumor-intrinsic genes pivotal for immune escape. In vitro and in vivo models demonstrated the role of baculoviral IAP repeat-containing protein 2 (BIRC2) in protecting HCC cells from immune killing.